To determine the function of podocyte ROCK2 in FSGS, WT and PR2KO mice were administered ADR intravenously (20 mg/kg) 4 weeks before morphological and biochemical analyses (Fig. 2a). The gene discussed is ROCK2; the disease is focal segmental glomerulosclerosis.